ENO1 and glioblastoma: This underscored the role of the “autophagy-secretion-TME remodeling” axis in chemoresistance and suggested that extracellular ENO1 accumulation exacerbated therapeutic resistance by recruiting immunosuppressive cells, offering a novel mechanistic explanation for GBM treatment failure.